Education
About Us
Working with TipRanks
Follow Us
Fmc Corp. (FMC)
NYSE:FMC
Earnings Data
Report Date
May 06, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.31Last Year’s EPS
0.18Same Quarter Last Year
Based on 10 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call balances clear operational progress and strategic actions (debt-reduction plan, strong Q4 cash generation, accelerating new active ingredients and an actionable manufacturing-cost reduction target) against material near-term headwinds (declining 2026 revenue guidance, a sharply weaker Q1 EBITDA and low Q1 margin, core portfolio competitiveness issues, negative FY2025 free cash flow, and broad generic pressure on Rynaxypyr). Management presented a concrete multi-year plan and initiated a strategic review to maximize shareholder value, but 2026 is positioned as a challenging transition year.Company Guidance
Strategic Review and Potential Sale
Board authorized a formal strategic review including potential sale of the company; financial and legal advisers retained. This process runs in parallel with operational execution to maximize shareholder value.
Debt Reduction Plan and India Sale Progress
Targeting >$1 billion of debt paydown in 2026 via asset sales and licensing (including sale of India commercial business). India sale progressing with binding bids expected in Q2 2026.
Strong Quarter Cash Generation and Reduced Net Debt
Q4 GAAP cash from operations of $657 million (+$230 million vs prior year quarter) and Q4 free cash flow of $623 million. Net debt at quarter end ~ $3.5 billion, down >$550 million vs Q3.
New Active Ingredients: Rapid Growth and Long-Term Upside
Sales of four new active ingredients grew ~54% from ~$130 million in 2024 to ~$200 million in 2025. 2026 sales for new actives guided to $300–$400 million; management still expects >$2 billion of cumulative sales by 2035.
Rynaxypyr Branded Earnings Expected to Hold
Despite post-patent generic entry, branded Rynaxypyr earnings are expected to be in line with prior year in 2026 due to higher volumes of advanced offerings and lower costs offsetting lower prices.
Focused Operational Priorities and Manufacturing Cost Target
Clear operational priorities: strengthen balance sheet, improve competitiveness of core portfolio, execute post-patent Rynaxypyr strategy, and grow new actives. Target to lower manufacturing cost of non-diamide products by at least 35% by 2027.
Improved Liquidity and Covenant Flexibility
Reworked revolving credit facility with covenant covenant allowance (6x through 2026) and plan to manage upcoming $500 million bond maturity (October) with refinancing intent in H1 2026.
FMC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
FMC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 04, 2026 | $16.99 | $13.67 | -19.54% |
Oct 29, 2025 | $29.04 | $15.53 | -46.52% |
Jul 30, 2025 | $40.61 | $38.36 | -5.54% |
Apr 30, 2025 | $40.64 | $37.27 | -8.28% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Fmc Corp. (FMC) report earnings?
Fmc Corp. (FMC) is schdueled to report earning on May 06, 2026, After Close (Confirmed).
What is Fmc Corp. (FMC) earnings time?
Fmc Corp. (FMC) earnings time is at May 06, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is FMC EPS forecast?
FMC EPS forecast for the fiscal quarter 2026 (Q1) is -0.31.